Eosinophil-mediated lung inflammation associated with elevated natural killer T cell response in COVID-19 patients
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Coronavirus disease 2019 (COVID-19) is associated with acute respiratory syndrome. The mechanisms underlying the different degrees of pneumonia severity in patients with COVID-19 remain elusive. This study provides evidence that COVID-19 is associated with eosinophil-mediated inflammation. Methods: We performed a retrospective case series of three patients with laboratory and radiologically confirmed COVID-19 pneumonia admitted to Chosun University Hospital. Demographic and clinical data on inflammatory cell lung infiltration and cytokine levels in patients with COVID-19 were collected. Results: Cytological analysis of sputum, tracheal aspirates, and bronchoalveolar lavage fluid (BALF) samples from all three patients revealed massive infiltration of polymorphonuclear cells (PMNs), such as eosinophils and neutrophils. All sputum and BALF specimens contained high levels of eosinophil cationic proteins. The infiltration of PMNs into the lungs, together with elevated levels of natural killer T (NKT) cells in BALF and peripheral blood samples from patients with severe pneumonia in the acute phase was confirmed by flow cytometry. Conclusions: These results suggest that the lungs of COVID-19 patients can exhibit eosinophil-mediated inflammation, together with an elevated NKT cell response, which is associated with COVID-19 pneumonia.
Abstract
Background/Aims: Coronavirus disease 2019 (COVID-19) is associated with acute respiratory syndrome. The mechanisms underlying the different degrees of pneumonia severity in patients with COVID-19 remain elusive. This study provides evidence that COVID-19 is associated with eosinophil-mediated inflammation. Methods: We performed a retrospective case series of three patients with laboratory and radiologically confirmed COVID-19 pneumonia admitted to Chosun University Hospital. Demographic and clinical data on inflammatory cell lung infiltration and cytokine levels in patients with COVID-19 were collected. Results: Cytological analysis of sputum, tracheal aspirates, and bronchoalveolar lavage fluid (BALF) samples from all three patients revealed massive infiltration of polymorphonuclear cells (PMNs), such as eosinophils and neutrophils. All sputum and BALF specimens contained high levels of eosinophil cationic proteins. The infiltration of PMNs into the lungs, together with elevated levels of natural killer T (NKT) cells in BALF and peripheral blood samples from patients with severe pneumonia in the acute phase was confirmed by flow cytometry. Conclusions: These results suggest that the lungs of COVID-19 patients can exhibit eosinophil-mediated inflammation, together with an elevated NKT cell response, which is associated with COVID-19 pneumonia.
참고문헌 (31)
- Zhu N, "A novel coronavirus from patients with pneumonia in China, 2019", N Engl J Med, 382, pp.727~733 (2020)
- Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, "The species severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and naming it SARS-CoV-2", Nat Microbiol, 5, pp.536~544 (2020)
- Eu Suk Kim, "Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19", Journal of Korean Medical Science, 35(13), pp.1~12 (2020), 대한의학회[DOI]
- Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study", Lancet, 395, pp.1054~1062 (2020)
- Conway SP, "The chest radiograph in cystic fibrosis : a new scoring system compared with the Chrispin-Norman and Brasfield scores", Thorax, 49, pp.860~862 (1994)
- Barnig C, "Circulating human eosinophils share a similar transcriptional profile in asthma and other hypereosinophilic disorders", PLoS One, 10, pp.e0141740~ (2015)
- Das R, "Transcriptional control of invariant NKT cell development", Immunol Rev, 238, pp.195~215 (2010)
- Yu YR, "Flow cytometric analysis of myeloid cells in human blood, bronchoalveolar lavage, and lung tissues", Am J Respir Cell Mol Biol, 54, pp.13~24 (2016)
- Godfrey DI, "NKT cells : what’s in a name?", Nat Rev Immunol, 4, pp.231~237 (2004)
- Dentone C, "Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy", BMC Infect Dis, 21, pp.353~ (2021)
- Liao M, "Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19", Nat Med, 26, pp.842~844 (2020)
- PandolfiL, "Broncho-alveolar inflammation in COVID-19 patients : a correlation with clinical outcome", BMC Pulm Med, 20, pp.301~ (2020)
- Fraenkel DJ, "Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects", Am J Respir Crit Care Med, 151(3 Pt 1), pp.879~886 (1995)
- Harrison AM, "Respiratory syncytical virus-induced chemokine expression in the lower airways : eosinophil recruitment and degranulation", Am J Respir Crit Care Med, 159, pp.1918~1924 (1999)
- Jeon EJ, "Acute eosinophilic pneumonia associated with 2009 influenza A(H1N1)", Thorax, 65, pp.268~270 (2010)
- LeMessurier KS, "Influenza A virus directly modulates mouse eosinophil responses", J Leukoc Biol, 108, pp.151~168 (2020)
- Cavalli E, "Transcriptomic analysis of COVID‑19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection", Int J Mol Med, 46, pp.1266~1273 (2020)
- Bilenki L, "Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production", Eur J Immunol, 34, pp.345~354 (2004)
- Lee SY, "Natural killer T cell sensitization during neonatal respiratory syncytial virus infection induces eosinophilic lung disease in re-infected adult mice", PLoS One, 12, pp.e0176940~ (2017)
- Papakosta D, "Bronchoalveolar lavage fluid eosinophils are correlated to natural killer cells in eosinophilic pneumonias", Respiration, 78, pp.177~184 (2009)
- Kimura H, "Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells", J Allergy Clin Immunol, 146, pp.80~88 (2020)
- De Giacomi F, "Acute eosinophilic pneumonia : causes, diagnosis, and management", Am J Respir Crit Care Med, 197, pp.728~736 (2018)
- Qin C, "Dysregulation of immune response in patients with coronavirus 2019(COVID-19)in Wuhan, China", Clin Infect Dis, 71, pp.762~768 (2020)
- Scott-Taylor TH, "Immunoglobulin G; structure and functional implications of different subclass modifications in initiation and resolution of allergy", Immun Inflamm Dis, 6, pp.13~33 (2018)
- Russell CD, "Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury", Lancet, 395, pp.473~475 (2020)
- RECOVERY Collaborative Group, "Dexamethasone in hospitalized patients with COVID-19", N Engl J Med, 384, pp.693~704 (2021)
- Wu C, "Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China", JAMA Intern Med, 180, pp.934~943 (2020)
- Jacobson KA, "Historical and current adenosine receptor agonists in preclinical and clinical development", Front Cell Neurosci, 13, pp.124~ (2019)
- Heulens N, "Innate immune modulation in chronic obstructive pulmonary disease : moving closer toward vitamin D therapy", J Pharmacol Exp Ther, 353, pp.360~368 (2015)
- Panarese A, "Letter : COVID-19, and vitamin D", Aliment Pharmacol Ther, 51, pp.993~995 (2020)
- Chen L, "Convalescent plasma as a potential therapy for COVID-19", Lancet Infect Dis, 20, pp.398~400 (2020)